Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel Mo/Cu co-catalyzed method for 3-trifluoromethyl-1,2,4-triazoles. Enhance purity and reduce costs in API manufacturing with scalable solutions.
Patent CN110467555A reveals mild chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates. Enables cost reduction and supply chain reliability for global buyers.
Novel isoindolone-based antitumor compound synthesis via patent CN119874717B. Mild conditions, high yield. Reliable pharmaceutical intermediate supplier for scale-up.
Discover advanced axial chiral styrene tertiary amine thiourea catalysts offering superior enantioselectivity and mild reaction conditions for pharmaceutical intermediate manufacturing.
Patent CN112916042B discloses a robust tetramethylspirodihydroindene catalyst enabling high enantioselectivity in glycine alkylations, offering cost-effective API manufacturing solutions.
Patent CN111978265B details a cost-effective FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant supply chain advantages for API manufacturers.
Patent CN108864189A reveals a novel one-pot synthesis for sulfinamide chiral ligands, enabling cost-effective production of high-purity pharmaceutical intermediates via asymmetric Heck reactions.
Patent CN114560832A reveals a green two-step route to dibenzofurans using visible light and palladium catalysis, offering cost-effective manufacturing solutions.
Patent CN115385916B details a novel chiral phosphoric acid catalyzed route offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110452150B details a mild, one-step synthesis of axial chiral indole-naphthalenes with high enantioselectivity, offering cost-effective solutions for chiral catalyst manufacturing.
Patent CN121378226A reveals a mild synthesis method for oxindole compounds with high yield. This offers cost reduction and supply reliability for pharmaceutical intermediates.
Novel Ru-catalyzed blue light method for 1,2,3-triazole quinoxalinones. High yield, mild conditions, reliable pharmaceutical intermediate supply chain solution.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Novel reductive amination route for bromhexine hydrochloride offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Novel acid-catalyzed cyclization for fused biindoles. Mild conditions, high purity, scalable process for pharmaceutical intermediates and drug discovery.
Patent CN105056991B reveals spirocyclic phosphazene catalysts enabling high ee asymmetric synthesis. Offers cost reduction and scalable supply for pharma intermediates.
Novel cinchona alkaloid catalyzed method for chiral chromene derivatives. High enantioselectivity up to 99% ee. Cost-effective manufacturing solution for pharmaceutical intermediates.
Patent CN113307778A reveals a mild Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles. This method offers scalable, cost-effective manufacturing for high-purity pharmaceutical intermediates.
Patent CN114456089B details a novel cobalt-catalyzed three-component reaction enabling efficient synthesis of amino-nitrile pharmaceutical intermediates with reduced costs.
Novel AlCl3-catalyzed route offers high stereoselectivity and mild conditions for scalable production of key pharmaceutical intermediates.